-
-
-
-
-
-
-
Baxter Announces Early Tender Results for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027
-
-
-
-
-
-
-
Baxter Reports Second-Quarter 2025 Results
-
-
-
-
-
-
-
Baxter Kidney Care is Now Vantive, A New Standalone Vital Organ Therapy Company
-
-
-
-
-
-
-
Baxter Announces Definitive Agreement to Divest Its Vantive Kidney Care Segment to Carlyle for $3.8 Billion
-
-
-
-
-
-
-
Baxter Reports Fourth-Quarter and Full-Year 2023 Results
-
-
-
-
-
-
-
Baxter Publishes Annual Corporate Responsibility Report, Reinforcing Longstanding Commitment to Making a Meaningful Difference
-
-
-
-
-
-
-
Pre-Open Movers: Meta, Qualcomm Fall; Renewable Stocks Up on Schumer/Manchin Deal
-
1,177,099 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

